A detailed history of Cidel Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cidel Asset Management Inc holds 644 shares of LLY stock, worth $591,192. This represents 0.04% of its overall portfolio holdings.

Number of Shares
644
Previous 767 16.04%
Holding current value
$591,192
Previous $447,000 12.08%
% of portfolio
0.04%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $72,840 - $97,450
-123 Reduced 16.04%
644 $501,000
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $402,820 - $474,872
767 New
767 $447,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $872B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.